AcuCort AB Statistics
Total Valuation
AcuCort AB has a market cap or net worth of SEK 163.41 million. The enterprise value is 136.40 million.
| Market Cap | 163.41M |
| Enterprise Value | 136.40M |
Important Dates
The last earnings date was Friday, February 20, 2026.
| Earnings Date | Feb 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AcuCort AB has 234.44 million shares outstanding. The number of shares has increased by 43.69% in one year.
| Current Share Class | 234.44M |
| Shares Outstanding | 234.44M |
| Shares Change (YoY) | +43.69% |
| Shares Change (QoQ) | -57.82% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | -0.82% |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 24.45 |
| PB Ratio | 2.56 |
| P/TBV Ratio | 2.71 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.21 |
| EV / Sales | 20.41 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.08
| Current Ratio | 8.08 |
| Quick Ratio | 8.02 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -90.73 |
Financial Efficiency
Return on equity (ROE) is -50.08% and return on invested capital (ROIC) is -31.66%.
| Return on Equity (ROE) | -50.08% |
| Return on Assets (ROA) | -29.45% |
| Return on Invested Capital (ROIC) | -31.66% |
| Return on Capital Employed (ROCE) | -41.56% |
| Weighted Average Cost of Capital (WACC) | 12.59% |
| Revenue Per Employee | 1.67M |
| Profits Per Employee | -6.55M |
| Employee Count | 4 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.87% in the last 52 weeks. The beta is 1.52, so AcuCort AB's price volatility has been higher than the market average.
| Beta (5Y) | 1.52 |
| 52-Week Price Change | -7.87% |
| 50-Day Moving Average | 0.72 |
| 200-Day Moving Average | 0.68 |
| Relative Strength Index (RSI) | 35.59 |
| Average Volume (20 Days) | 927,770 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AcuCort AB had revenue of SEK 6.68 million and -26.19 million in losses. Loss per share was -0.22.
| Revenue | 6.68M |
| Gross Profit | -13.77M |
| Operating Income | -26.49M |
| Pretax Income | -26.19M |
| Net Income | -26.19M |
| EBITDA | -18.34M |
| EBIT | -26.49M |
| Loss Per Share | -0.22 |
Balance Sheet
The company has 27.01 million in cash and n/a in debt, with a net cash position of 27.01 million or 0.12 per share.
| Cash & Cash Equivalents | 27.01M |
| Total Debt | n/a |
| Net Cash | 27.01M |
| Net Cash Per Share | 0.12 |
| Equity (Book Value) | 63.74M |
| Book Value Per Share | 0.27 |
| Working Capital | 24.36M |
Cash Flow
| Operating Cash Flow | -18.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | -206.09% |
| Operating Margin | -396.42% |
| Pretax Margin | -391.89% |
| Profit Margin | n/a |
| EBITDA Margin | -274.47% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AcuCort AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -43.69% |
| Shareholder Yield | -43.69% |
| Earnings Yield | -16.03% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AcuCort AB has an Altman Z-Score of 23.07 and a Piotroski F-Score of 2.
| Altman Z-Score | 23.07 |
| Piotroski F-Score | 2 |